SG Americas Securities’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,768
| Closed | -$119K | – | 3229 |
|
|
2024
Q4 | $119K | Sell |
10,768
-4,149
| -28% | -$45.9K | ﹤0.01% | 2324 |
|
|
2024
Q3 | $183K | Sell |
14,917
-53,684
| -78% | -$659K | ﹤0.01% | 2289 |
|
|
2024
Q2 | $927K | Buy |
68,601
+58,943
| +610% | +$796K | 0.01% | 1230 |
|
|
2024
Q1 | $130K | Sell |
9,658
-5,443
| -36% | -$73.3K | ﹤0.01% | 2083 |
|
|
2023
Q4 | $79K | Buy |
15,101
+1,544
| +11% | +$8.08K | ﹤0.01% | 2580 |
|
|
2023
Q3 | $53K | Buy |
+13,557
| New | +$53K | ﹤0.01% | 2630 |
|
|
2022
Q4 | – | Sell |
-7,933
| Closed | -$102K | – | 2964 |
|
|
2022
Q3 | $102K | Buy |
+7,933
| New | +$102K | ﹤0.01% | 2554 |
|
|
2022
Q2 | – | Sell |
-182,591
| Closed | -$3.84M | – | 3180 |
|
|
2022
Q1 | $3.84M | Buy |
182,591
+152,149
| +500% | +$3.2M | 0.03% | 463 |
|
|
2021
Q4 | $730K | Sell |
30,442
-11,372
| -27% | -$273K | ﹤0.01% | 1700 |
|
|
2021
Q3 | $1.06M | Buy |
41,814
+24,697
| +144% | +$628K | 0.01% | 1708 |
|
|
2021
Q2 | $576K | Buy |
17,117
+2,649
| +18% | +$89.1K | ﹤0.01% | 1697 |
|
|
2021
Q1 | $562K | Buy |
+14,468
| New | +$562K | ﹤0.01% | 1769 |
|
|
2020
Q4 | – | Sell |
-25,526
| Closed | -$855K | – | 2899 |
|
|
2020
Q3 | $855K | Buy |
25,526
+246
| +1% | +$8.24K | 0.01% | 1061 |
|
|
2020
Q2 | $602K | Buy |
25,280
+18,497
| +273% | +$440K | 0.01% | 1628 |
|
|
2020
Q1 | $155K | Buy |
6,783
+2,691
| +66% | +$61.5K | ﹤0.01% | 2274 |
|
|
2019
Q4 | $116K | Buy |
+4,092
| New | +$116K | ﹤0.01% | 2471 |
|
|
2019
Q3 | – | Sell |
-13,400
| Closed | -$391K | – | 2633 |
|
|
2019
Q2 | $391K | Buy |
+13,400
| New | +$391K | ﹤0.01% | 1769 |
|